Long Term Debt Summary of IXICO plc

IXICO plc's latest annual long term debt in 2023 was 275 Thousand USD , down -30.2% from previous year.
IXICO plc's latest quarterly long term debt in 2024 Q1 was 265.16 Thousand GBP , down 0.0% from previous quarter.
IXICO plc reported annual long term debt of 394 Thousand USD in 2022, down -24.08% from previous year.
IXICO plc reported annual long term debt of 519 Thousand USD in 2021, up 1053.33% from previous year.
IXICO plc reported quarterly long term debt of 262.47 Thousand USD for 2024 Q2, down 0.0% from previous quarter.
IXICO plc reported quarterly long term debt of 275 Thousand USD for 2023 Q4, down -21.26% from previous quarter.

Annual Long Term Debt Chart of IXICO plc (2023 - 1993)

Historical Annual Long Term Debt of IXICO plc (2023 - 1993)

Year	Long Term Debt	Long Term Debt Growth
2023	275 Thousand USD	-30.2%
2022	394 Thousand USD	-24.08%
2021	519 Thousand USD	1053.33%
2020	45 Thousand USD	0.0%
2019	- USD	0.0%
2018	- GBP	0.0%
2017	- GBP	0.0%
2016	- GBP	0.0%
2015	- GBP	0.0%
2014	- GBP	0.0%
2013	- GBP	0.0%
2012	- GBP	0.0%
2011	- GBP	0.0%
2010	- GBP	0.0%
2009	- GBP	0.0%
2008	- GBP	0.0%
2007	- GBP	0.0%
2006	- GBP	0.0%
2005	- GBP	0.0%
2004	- GBP	0.0%
2003	- GBP	0.0%
2002	- GBP	-100.0%
2001	14 Thousand GBP	-78.13%
2000	64 Thousand GBP	16.36%
1999	55 Thousand GBP	12.24%
1998	49 Thousand GBP	22.5%
1997	40 Thousand GBP	5.26%
1996	38 Thousand GBP	533.33%
1995	6000.00 GBP	-33.33%
1994	9000.00 GBP	-10.0%
1993	10 Thousand GBP	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	265.16 Thousand GBP	0.0%
2024 Q2	262.47 Thousand USD	0.0%
2023 Q4	275 Thousand USD	-21.26%
2023 Q1	388.04 Thousand GBP	-1.51%
2023 Q3	349.23 Thousand GBP	8.8%
2023 Q2	321 Thousand USD	-17.28%
2023 FY	275 Thousand USD	-30.2%
2022 Q1	634.23 Thousand GBP	22.2%
2022 Q2	469 Thousand GBP	-26.05%
2022 Q3	479.6 Thousand GBP	2.26%
2022 FY	394 Thousand USD	-24.08%
2022 Q4	394 Thousand USD	-17.85%
2021 Q3	717.91 Thousand GBP	31.01%
2021 Q1	749.4 Thousand GBP	1565.34%
2021 FY	519 Thousand USD	1053.33%
2021 Q4	519 Thousand GBP	-27.71%
2021 Q2	548 Thousand GBP	-26.87%
2020 Q4	45 Thousand GBP	-19.29%
2020 Q1	- GBP	0.0%
2020 Q2	- GBP	0.0%
2020 FY	45 Thousand USD	0.0%
2020 Q3	55.75 Thousand GBP	0.0%
2019 Q2	- GBP	0.0%
2019 FY	- USD	0.0%
2019 Q3	- GBP	0.0%
2019 Q1	- GBP	0.0%
2019 Q4	- GBP	0.0%
2018 Q2	- GBP	0.0%
2018 FY	- GBP	0.0%
2018 Q4	- GBP	0.0%
2018 Q3	- GBP	0.0%
2018 Q1	- GBP	0.0%
2017 FY	- GBP	0.0%
2017 Q4	- GBP	0.0%
2017 Q3	- GBP	0.0%
2017 Q2	- GBP	0.0%
2017 Q1	- GBP	0.0%
2016 Q3	- GBP	0.0%
2016 FY	- GBP	0.0%
2016 Q2	- GBP	0.0%
2016 Q1	- GBP	0.0%
2016 Q4	- GBP	0.0%
2015 Q2	- GBP	0.0%
2015 FY	- GBP	0.0%
2015 Q3	- GBP	0.0%
2015 Q1	- GBP	0.0%
2015 Q4	- GBP	0.0%
2014 FY	- GBP	0.0%
2014 Q1	- GBP	0.0%
2014 Q4	- GBP	0.0%
2014 Q2	- GBP	0.0%
2013 FY	- GBP	0.0%
2013 Q2	- GBP	0.0%
2013 Q4	- GBP	0.0%
2012 Q4	- GBP	0.0%
2012 FY	- GBP	0.0%
2012 Q2	- GBP	0.0%
2011 FY	- GBP	0.0%
2011 Q2	- GBP	0.0%
2011 Q4	- GBP	0.0%
2010 Q2	- GBP	0.0%
2010 FY	- GBP	0.0%
2010 Q4	- GBP	0.0%
2009 Q4	- GBP	0.0%
2009 Q2	- GBP	0.0%
2009 FY	- GBP	0.0%
2008 Q4	- GBP	0.0%
2008 FY	- GBP	0.0%
2008 Q2	- GBP	0.0%
2007 FY	- GBP	0.0%
2007 Q2	- GBP	0.0%
2006 Q4	- GBP	0.0%
2006 Q2	- GBP	0.0%
2006 FY	- GBP	0.0%
2005 Q4	- GBP	0.0%
2005 FY	- GBP	0.0%
2005 Q2	- GBP	0.0%
2004 Q2	- GBP	0.0%
2004 Q4	- GBP	0.0%
2004 FY	- GBP	0.0%
2003 Q4	- GBP	0.0%
2003 FY	- GBP	0.0%
2003 Q2	- GBP	0.0%
2002 Q2	- GBP	0.0%
2002 FY	- GBP	-100.0%
2002 Q4	- GBP	0.0%
2001 FY	14 Thousand GBP	-78.13%
2000 FY	64 Thousand GBP	16.36%
1999 FY	55 Thousand GBP	12.24%
1998 FY	49 Thousand GBP	22.5%
1997 FY	40 Thousand GBP	5.26%
1996 FY	38 Thousand GBP	533.33%
1995 FY	6000.00 GBP	-33.33%
1994 FY	9000.00 GBP	-10.0%
1993 FY	10 Thousand GBP	0.0%

Peer Long Term Debt Comparison of IXICO plc

Name	Long Term Debt	Long Term Debt Difference
Burzynski Research Institute, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	- USD	-Infinity%
Evofem Biosciences, Inc.	8000.00 USD	-3337.5%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
Santhera Pharmaceuticals Holding AG	1.75 Million USD	84.335%
Qrons Inc.	80 Thousand USD	-243.75%
Adynxx, Inc.	- USD	-Infinity%
Neon Bloom, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	20.31 Million USD	98.646%
ProtoKinetix, Incorporated	- USD	-Infinity%
Skye Bioscience, Inc.	171.23 Thousand USD	-60.603%
Eiger BioPharmaceuticals, Inc.	- USD	-Infinity%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
SQZ Biotechnologies Company	20.9 Million USD	98.685%
Intellipharmaceutics International Inc.	- USD	-Infinity%
Propanc Biopharma, Inc.	58.64 Thousand USD	-368.947%
Mesoblast Limited	100.29 Million USD	99.726%
Marizyme, Inc.	667.12 Thousand USD	58.779%
Genus plc	228.2 Million USD	99.879%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
Pharming Group N.V.	166.1 Million USD	99.834%
Therapeutic Solutions International, Inc.	5512.00 USD	-4889.115%
CNBX Pharmaceuticals Inc.	- USD	-Infinity%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
ContraFect Corporation	2.21 Million USD	87.557%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	1.4 Million USD	80.398%
IMV Inc.	27.39 Million USD	98.996%
AXIM Biotechnologies, Inc.	5.42 Million USD	94.932%
MultiCell Technologies, Inc.	36.43 USD	-754772.358%
ONE Bio Corp.	592.19 Thousand USD	53.563%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	55.61 Million USD	99.506%
Arno Therapeutics, Inc.	- USD	-Infinity%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	2.22 Million USD	87.646%
Mosaic ImmunoEngineering Inc.	1.22 Million USD	77.612%
Biomind Labs Inc.	- USD	-Infinity%
American Oriental Bioengineering, Inc.	554.59 Thousand USD	50.414%
Provectus Biopharmaceuticals, Inc.	25.29 Thousand USD	-986.999%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Oncotelic Therapeutics, Inc.	1.89 Million USD	85.515%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Acro Biomedical Co., Ltd.	- USD	-Infinity%
Curative Biotechnology, Inc.	- USD	-Infinity%
GB Sciences, Inc.	322 Thousand USD	14.596%
Alpha Cognition Inc.	- USD	-Infinity%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	11.23 Billion USD	99.998%
Wesana Health Holdings Inc.	- USD	-Infinity%
Halberd Corporation	150 Thousand USD	-83.333%
Enzolytics Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
Resverlogix Corp.	- USD	-Infinity%
Nuo Therapeutics, Inc.	164.2 Thousand USD	-67.474%
MetaStat, Inc.	- USD	-Infinity%
argenx SE	15.35 Million USD	98.209%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	- USD	-Infinity%
Zenith Capital Corp.	4456.00 USD	-6071.454%
Genscript Biotech Corporation	287.12 Million USD	99.904%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	126.3 Thousand USD	-117.732%
WPD Pharmaceuticals Inc.	229.29 Thousand USD	-19.935%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
Kadimastem Ltd	229.69 Thousand USD	-19.726%
Helix BioMedix, Inc.	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	8.26 Million USD	96.672%
BioStem Technologies, Inc.	265.63 Thousand USD	-3.526%
Oncology Pharma Inc.	- USD	-Infinity%
Reve Technologies, Inc.	1064.00 USD	-25745.865%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	149.61 Thousand USD	-83.806%
Regen BioPharma, Inc.	149.61 Thousand USD	-83.806%
NovAccess Global Inc.	- USD	-Infinity%
Affymax, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
CytoDyn Inc.	141 Thousand USD	-95.035%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	7.81 Million USD	96.483%
SYBLEU INC	300 Thousand USD	8.333%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	369.04 Thousand USD	25.484%
International Stem Cell Corporation	445 Thousand USD	38.202%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	8.15 Million USD	96.626%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	457 Thousand USD	39.825%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	1.16 Million USD	76.314%
PureTech Health plc	18.25 Million USD	98.493%
Coeptis Therapeutics, Inc.	150 Thousand USD	-83.333%
IntelGenx Technologies Corp.	11.83 Million USD	97.677%
Gelesis Holdings, Inc.	26.3 Million USD	98.955%
CSL Limited	11.23 Billion USD	99.998%
Cellectis S.A.	36.21 Million USD	99.241%

Global Stocks Search

IXICO plc (PHYOF)

Long Term Debt Summary of IXICO plc

Annual Long Term Debt Chart of IXICO plc (2023 - 1993)

Historical Annual Long Term Debt of IXICO plc (2023 - 1993)

Peer Long Term Debt Comparison of IXICO plc